Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,657,100 | 2,337,500 | 7,320,700 | 6,536,200 | 4,582,100 |
| Marketable Securities | 24,200 | 101,000 | 88,200 | 1,497,900 | 1,456,500 |
| Receivables | 6,929,000 | 5,541,500 | 5,776,800 | 5,262,200 | 4,766,300 |
| Inventories | 3,980,300 | 3,190,700 | 3,098,100 | 4,458,300 | 3,561,900 |
| Other current assets | 0 | 0 | 2,229,100 | 0 | 0 |
| TOTAL | $17,462,100 | $13,709,600 | $20,549,600 | $19,202,100 | $15,101,400 |
| Non-Current Assets | |||||
| PPE Net | 8,681,900 | 7,872,900 | 7,996,100 | 8,826,500 | 8,252,600 |
| Investments And Advances | 2,966,800 | 1,962,400 | 2,005,400 | 5,678,800 | 5,207,500 |
| Intangibles | 7,450,000 | 6,618,000 | 1,068,000 | 4,029,200 | 4,357,900 |
| Other Non-Current Assets | 10,072,300 | 9,123,200 | 12,289,300 | 7,244,400 | 5,886,500 |
| TOTAL | $29,171,000 | $25,576,500 | $23,358,800 | $25,778,900 | $23,704,500 |
| Total Assets | $46,633,100 | $39,286,100 | $43,908,400 | $44,981,000 | $38,805,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,700 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,606,700 | 1,405,300 | 1,207,100 | 1,410,700 | 1,349,300 |
| Other current liabilities | 9,600,500 | 8,038,500 | 7,841,800 | 8,295,100 | 7,032,700 |
| TOTAL | $12,481,600 | $11,775,200 | $11,888,100 | $14,535,900 | $10,986,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,586,600 | 13,817,900 | 9,196,400 | 9,940,500 | 8,367,800 |
| Other Non-Current Liabilities | 9,639,800 | 8,806,400 | 10,602,100 | 8,836,700 | 5,371,000 |
| TOTAL | $28,326,300 | $24,811,800 | $21,111,200 | $18,777,200 | $13,738,800 |
| Total Liabilities | $40,807,900 | $36,587,000 | $32,999,300 | $33,313,100 | $24,725,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 958,426 | 956,382 | 1,035,419 | 1,095,598 | 1,103,352 |
| Common Shares | 598,200 | 598,800 | 661,000 | 687,900 | 688,500 |
| Retained earnings | 7,830,200 | 4,920,400 | 11,395,900 | 13,894,100 | 16,046,300 |
| Other shareholders' equity | -9,325,700 | -9,444,400 | -7,662,400 | -8,655,900 | -8,213,900 |
| TOTAL | $5,825,200 | $2,699,100 | $10,909,100 | $11,667,900 | $14,080,500 |
| Total Liabilities And Equity | $46,633,100 | $39,286,100 | $43,908,400 | $44,981,000 | $38,805,900 |